Skip to main content
NIH funding notice RFA-AG-18-026

From Association to Function in the Alzheimers Disease Post-Genomics Era (R01 - Clinical Trial Not Allowed)

Closed on March 28, 2018.

Posted
December 14, 2017
Close date
March 28, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,268,051 in first-year total cost, median $634,026.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 MDCN-P (50)]2

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY1
  2. SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE1
Competing awards under RFA-AG-18-026 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Novel roles for the Alzheimer's Disease (AD) risk gene, SORLA in neuroprotection in AD1R01AG061875-01HUANG, TIMOTHY YIKAISANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA$682,426ZRG1
2018Proteome-wide analysis of AD-associated SNPs1R01AG061852-01ZHU, HENGJOHNS HOPKINS UNIVERSITY, MD$585,625ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.